ストックスクリーナーアプリを入手
2.00
3.85%
-0.08
前日終値:
$2.08
開ける：
$2.08
24時間の取引高:
204.16K
Relative Volume:
0.73
時価総額：
$125.93M
収益：
$233.00K
当期純損益:
$-64.61M
株価収益率:
-1.7337
EPS:
-1.1536
ネットキャッシュフロー:
$-58.32M
1週間 パフォーマンス:
-4.76%
1か月 パフォーマンス:
-15.97%
6か月 パフォーマンス:
-13.04%
1年 パフォーマンス:
+99.98%
1日の値動き範囲:
$1.93
$2.1573
1週間の範囲:
$1.93
$2.2789
52週間の値動き範囲:
$0.91
$3.82
Connect Biopharma Holdings Ltd Stock (CNTB) Company Profile
名前
Connect Biopharma Holdings Ltd
セクター
電話
858-727-1040
住所
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
Compare CNTB vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CNTB
Connect Biopharma Holdings Ltd
|
2.00 | 125.93M | 233.00K | -64.61M | -58.32M | -1.1536 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Connect Biopharma Holdings Ltd Stock (CNTB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-01 | 開始されました | Lake Street | Buy |
| 2025-10-31 | 開始されました | BTIG Research | Buy |
| 2025-06-12 | 開始されました | H.C. Wainwright | Buy |
| 2024-03-04 | 開始されました | H.C. Wainwright | Buy |
| 2021-04-13 | 開始されました | Jefferies | Buy |
| 2021-04-13 | 開始されました | Piper Sandler | Overweight |
| 2021-04-13 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Connect Biopharma Holdings Ltd (CNTB) 最新ニュース
Connect Biopharma Holdings Ltd (CNTB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
H.C. Wainwright reiterates Buy on Connect Biopharma stock at $7 By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Buy on Connect Biopharma stock at $7 - Investing.com
Connect Biopharma Holdings Ltd - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Connect Biopharma stock rises after Phase 2 asthma study enrollment By Investing.com - Investing.com South Africa
Connect Biopharma stock rises after Phase 2 asthma study enrollment - Investing.com
Connect Biopharma completes asthma trial enrollment - Investing.com
Connect Biopharma finishes asthma study enrollment, data due in September - Stock Titan
Connect Biopharma Holdings Ltd (CNTB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CNTB Stock Price, Quote & Chart - ChartMill
Connect Biopharma touts Rademikibart's edge as SEABREEZE data looms in 2026 - MSN
CNTB Technical Analysis | Trend, Signals & Chart Patterns | CONNECT BIOPHARMA HOLDINGS L (NASDAQ:CNTB) - ChartMill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Connect Biopharma director James Huang acquires $371,610 in shares - Investing.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Connect Biopharma director James Huang acquires $371,610 in shares By Investing.com - Investing.com UK
Director-linked fund boosts Connect Biopharma (NASDAQ: CNTB) stake - Stock Titan
[EFFECT] Connect Biopharma Holdings Ltd SEC Filing - Stock Titan
Connect Biopharma (CNTB) Gains 4.6% as Shares Test Key Resistance at $2.61Earnings Beat Stocks - newsline.com
This Avalyn Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Canaccord Genuity Initiates Connect Biopharma at Buy With $6 Price Target - Moomoo
Connect Biopharma Touts Rademikibart’s Edge as SEABREEZE Data Looms in 2026 - inkl
Cantor Fitzgerald initiates Connect Biopharma stock with overweight rating - Investing.com
Cantor Fitzgerald initiates Connect Biopharma stock with overweight rating By Investing.com - Investing.com South Africa
Connect Biopharma Growth Plans Raise Financial Discipline Focus - Kalkine Media
Here's Why Connect Biopharma Holdings (NASDAQ:CNTB) Must Use Its Cash Wisely - simplywall.st
Why Is Connect Biopharma Holdings Limited (CNTB) Stock Down Today? - Meyka
Wei Zheng holds 6.2% of Connect Biopharma (CNTB) after March offering - Stock Titan
Companies Like Connect Biopharma Holdings (NASDAQ:CNTB) Could Be Quite Risky - Yahoo Finance
Connect Biopharma (CNTB) files resale registration for 6.13M shares - Stock Titan
Connect Biopharma | F-3: Registration statement for specified transactions by certain foreign private issuers - Moomoo
Connect Biopharma : Corporate PresentationMay 2026 (3b1153) - marketscreener.com
BTIG Maintains Connect Biopharma(CNTB.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Connect Biopharma to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference - The Manila Times
Connect Biopharma 4Q Loss/Shr 34c >CNTB - Moomoo
Connect Biopharma Holdings Ltd 2026 Q1 Financial Report: Earnings, Cash Flow & Company Overview - Minichart
Connect Biopharma Holdings Releases Q1 2026 Financial Results - AlphaStreet
Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Connect Biopharma Holdings Ltd 1Q 2026: Revenue $169K, EPS ($0.34) — 10-Q Summary - TradingView
Connect Biopharma (NASDAQ: CNTB) boosts R&D and cash with Q1 2026 loss - Stock Titan
Connect Biopharma (NASDAQ: CNTB) widens Q1 loss as rademikibart trials advance - Stock Titan
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Sheboygan Press
BML Capital Management LLC Sells 858,613 Shares of Connect Biopharma Holdings Limited Sponsored ADR $CNTB - MarketBeat
Connect Biopharma Holdings Ltd (CNTB) 財務データ
収益
当期純利益
現金流量
EPS
0.74%
1.44%
大文字化:
|
ボリューム (24 時間):